Skip to main content
. 2016 Jul 28;6(6):522–530. doi: 10.1016/j.apsb.2016.06.013

Figure 1.

Fig. 1

The landscape of ischemic stroke drug discovery and therapy over the period 1995–2015. (A) The classification of 430 drug candidates by pie chart based on the mechanism of action: (B) the 4% of drugs on the market; (C) the 9% undergoing clinical trials; (D) the 17% undergoing preclinical evaluation and (E) the 70% of failed drug candidates.